clinical trials
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
clinical trials
Apr 22, 2024, 10:46 |
Blog
Everyone at Susan G. Komen is devastated to learn that Sheila Johnson passed away from metastatic breast cancer
Susan G. Komen shared on LinkedIn: "Everyone at Susan G. Komen is devastated to learn that…
Apr 21, 2024, 21:27 |
Drugs
Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…
Apr 19, 2024, 13:53 |
Dialogues
Oncothon: Discussion with Professor Eric Small on mentorship and challenges in pediatric cancer treatment
Oncothon is a global telethon spanning 24 hours, dedicated to gathering donations for childhood cancer…
Apr 19, 2024, 05:36 |
Career
St. Jude Children's Research Hospital has named Andrew Smith Diagnostic Imaging chair
St. Jude Children's Research Hospital shared a post on LinkedIn: "St. Jude has named Andrew…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
Apr 17, 2024, 00:56 |
Insight
Cathy Eng: I had an amazing opportunity to work with these phenomenal people
Cathy Eng shared a post on X: "I had an amazing opportunity to work with…
Apr 15, 2024, 04:04 |
Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Apr 14, 2024, 13:10 |
Blog
Herbert Loong: Had opportunity to welcome colleagues from Bayer AG Company
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post…
Apr 14, 2024, 10:33 |
Opinion
Elad Sharon: Designing clinical trials is all about tradeoffs
Elad Sharon, Clinical and Translational Director of Immunotherapy Toxicity Service at Dana-Farber Cancer Institute, shared…
Apr 13, 2024, 11:41 |
Insight
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at…
3
4
5
6
7
All:
172
Posts:
41 - 50
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube